VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
30 hedge funds and large institutions have $7.82M invested in VIVEVE MED INC in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
70% less capital invested
Capital invested by funds: $26M → $7.82M (-$18.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$171K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$7.59K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$5.42K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$5.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$2.79M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.26M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$566K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$559K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$250K |
VIVE Hedge Fund Activity: Q2 2019 in Review
30 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2019, worth a combined $7.82M — down 70% from $26M a quarter earlier.
Fund positioning in VIVE was balanced in Q2 2019: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 7 trimmed.
The largest buyer was Stifel Financial, opening a new position worth an estimated $171K. The largest seller was Hood River Capital Management, exiting entirely with an estimated $2.79M sold.
- 30 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $7.82M of VIVEVE MED INC stock for Q2 2019, down 70% quarter-over-quarter.
- 6 funds opened new VIVEVE MED INC positions in Q2 2019 and 6 closed out, a net change of 0 holders.
- The largest VIVEVE MED INC buyer in Q2 2019 was Stifel Financial, an estimated $171K added.
- The largest VIVEVE MED INC seller in Q2 2019 was Hood River Capital Management, an estimated $2.79M sold.
Based on aggregated 13F filings for Q2 2019.